BRNS — Barinthus Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Barinthus Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	11.4	43.3	214	194	142
Net Total Accounts Receivable
Net Total Receivables	3.91	3.23	6.95	10.4	7.94
Prepaid Expenses
Total Current Assets	16.2	47.9	227	213	157
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.79	2.76	9.09	15.7	19.4
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	19	50.7	281	270	215
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.75	7.64	11.2	12.2	12.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	7.72	54.2	28.6	27.3	27.7
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	11.3	-3.54	252	243	187
Total Liabilities & Shareholders' Equity	19	50.7	281	270	215
Total Common Shares Outstanding